abstract |
A compound of formula (I) is provided, wherein: ring A and ring B are each independently optionally substituted 5-6 membered monocyclic aryl or heteroaryl. The compounds are inhibitors of isocitrate dehydrogenase 2 (IDH2) mutants useful in the treatment of cancer. |